AKR1B1 inhibition using NARI-29-an Epalrestat analogue-alleviates Doxorubicin-induced cardiotoxicity via modulating Calcium/CaMKII/MuRF-1 axis.
Saved in:
| Title: | AKR1B1 inhibition using NARI-29-an Epalrestat analogue-alleviates Doxorubicin-induced cardiotoxicity via modulating Calcium/CaMKII/MuRF-1 axis. |
|---|---|
| Authors: | Syamprasad NP; Department of Pharmacology & Toxicology, National Institute of Pharmaceutical Education and Research Guwahati, Sila Village, Changsari, Assam, 781101, India., Jain S; Department of Pharmacology & Toxicology, National Institute of Pharmaceutical Education and Research Guwahati, Sila Village, Changsari, Assam, 781101, India., Rajdev B; Department of Pharmacology & Toxicology, National Institute of Pharmaceutical Education and Research Guwahati, Sila Village, Changsari, Assam, 781101, India., Panda SR; Department of Pharmacology & Toxicology, National Institute of Pharmaceutical Education and Research Guwahati, Sila Village, Changsari, Assam, 781101, India., Gangasani JK; Department of Pharmacology & Toxicology, National Institute of Pharmaceutical Education and Research Guwahati, Sila Village, Changsari, Assam, 781101, India., Challa VS; Department of Pharmacology & Toxicology, National Institute of Pharmaceutical Education and Research Guwahati, Sila Village, Changsari, Assam, 781101, India., Vaidya JR; Fluoro Agro Chemicals Department and AcSIR-Ghaziabad, CSIR-Indian Institute of Chemical Technology, Uppal Road Tarnaka, Hyderabad, Telangana, 500007, India., Kundu GC; Laboratory of Tumor Biology, Angiogenesis and Nanomedicine Research, National Centre for Cell Science (NCCS), Pune, 411007, India; School of Biotechnology, KIIT Deemed to Be University, Bhubaneswar, 751 024, India; Kalinga Institute of Medical Sciences (KIMS), KIIT Deemed to Be University, Bhubaneswar, 751024, India., Naidu VGM; Department of Pharmacology & Toxicology, National Institute of Pharmaceutical Education and Research Guwahati, Sila Village, Changsari, Assam, 781101, India. Electronic address: vgmnaidu@gmail.com. |
| Source: | Chemico-biological interactions [Chem Biol Interact] 2023 Aug 25; Vol. 381, pp. 110566. Date of Electronic Publication: 2023 May 29. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Country of Publication: Ireland NLM ID: 0227276 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7786 (Electronic) Linking ISSN: 00092797 NLM ISO Abbreviation: Chem Biol Interact Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 37257577 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: AKR1B1 inhibition using NARI-29-an Epalrestat analogue-alleviates Doxorubicin-induced cardiotoxicity via modulating Calcium/CaMKII/MuRF-1 axis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Syamprasad+NP%22">Syamprasad NP</searchLink>; Department of Pharmacology & Toxicology, National Institute of Pharmaceutical Education and Research Guwahati, Sila Village, Changsari, Assam, 781101, India.<br /><searchLink fieldCode="AU" term="%22Jain+S%22">Jain S</searchLink>; Department of Pharmacology & Toxicology, National Institute of Pharmaceutical Education and Research Guwahati, Sila Village, Changsari, Assam, 781101, India.<br /><searchLink fieldCode="AU" term="%22Rajdev+B%22">Rajdev B</searchLink>; Department of Pharmacology & Toxicology, National Institute of Pharmaceutical Education and Research Guwahati, Sila Village, Changsari, Assam, 781101, India.<br /><searchLink fieldCode="AU" term="%22Panda+SR%22">Panda SR</searchLink>; Department of Pharmacology & Toxicology, National Institute of Pharmaceutical Education and Research Guwahati, Sila Village, Changsari, Assam, 781101, India.<br /><searchLink fieldCode="AU" term="%22Gangasani+JK%22">Gangasani JK</searchLink>; Department of Pharmacology & Toxicology, National Institute of Pharmaceutical Education and Research Guwahati, Sila Village, Changsari, Assam, 781101, India.<br /><searchLink fieldCode="AU" term="%22Challa+VS%22">Challa VS</searchLink>; Department of Pharmacology & Toxicology, National Institute of Pharmaceutical Education and Research Guwahati, Sila Village, Changsari, Assam, 781101, India.<br /><searchLink fieldCode="AU" term="%22Vaidya+JR%22">Vaidya JR</searchLink>; Fluoro Agro Chemicals Department and AcSIR-Ghaziabad, CSIR-Indian Institute of Chemical Technology, Uppal Road Tarnaka, Hyderabad, Telangana, 500007, India.<br /><searchLink fieldCode="AU" term="%22Kundu+GC%22">Kundu GC</searchLink>; Laboratory of Tumor Biology, Angiogenesis and Nanomedicine Research, National Centre for Cell Science (NCCS), Pune, 411007, India; School of Biotechnology, KIIT Deemed to Be University, Bhubaneswar, 751 024, India; Kalinga Institute of Medical Sciences (KIMS), KIIT Deemed to Be University, Bhubaneswar, 751024, India.<br /><searchLink fieldCode="AU" term="%22Naidu+VGM%22">Naidu VGM</searchLink>; Department of Pharmacology & Toxicology, National Institute of Pharmaceutical Education and Research Guwahati, Sila Village, Changsari, Assam, 781101, India. Electronic address: vgmnaidu@gmail.com. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220227276%22">Chemico-biological interactions</searchLink> [Chem Biol Interact] 2023 Aug 25; Vol. 381, pp. 110566. <i>Date of Electronic Publication: </i>2023 May 29. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>Ireland <i>NLM ID: </i>0227276 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1872-7786 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200092797%22">00092797 </searchLink><i>NLM ISO Abbreviation: </i>Chem Biol Interact <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37257577 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.cbi.2023.110566 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 110566 Titles: – TitleFull: AKR1B1 inhibition using NARI-29-an Epalrestat analogue-alleviates Doxorubicin-induced cardiotoxicity via modulating Calcium/CaMKII/MuRF-1 axis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Syamprasad NP – PersonEntity: Name: NameFull: Jain S – PersonEntity: Name: NameFull: Rajdev B – PersonEntity: Name: NameFull: Panda SR – PersonEntity: Name: NameFull: Gangasani JK – PersonEntity: Name: NameFull: Challa VS – PersonEntity: Name: NameFull: Vaidya JR – PersonEntity: Name: NameFull: Kundu GC – PersonEntity: Name: NameFull: Naidu VGM IsPartOfRelationships: – BibEntity: Dates: – D: 25 M: 08 Text: 2023 Aug 25 Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 1872-7786 Numbering: – Type: volume Value: 381 Titles: – TitleFull: Chemico-biological interactions Type: main |
| ResultId | 1 |